Chinese version - The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.
The trend of cancer incidences is one of the key questions for developing critical illness (CI) and cancer insurance products with a sustainable price.
SCOR announces the publication of its interim financial report for the six months ended 30 June 2015
Financial report of the first semester of 2015.
Half year 2015 results.
SCOR delivers a strong performance for the first half of 2015 with a net income of EUR 327 million, up 28% from H1 2014.
SCOR delivers a strong performance for the first half of 2015 with a net income of EUR 327 million, up 28% from H1 2014.
SCOR delivers a strong performance for the first half of 2015 with a net income of EUR 327 million, up 28% from H1 2014
SCOR announces the publication of its interim financial report for the six months ended 30 June 2015
Over 35 million people in the world are HIVpositive. Again, as long as treatment and regular medical follow-up show an absence of immunosuppression, some of these people can be offered life cover.
Fitch Ratings has upgraded SCOR’s Insurer Financial Strength rating to ‘AA- stable outlook’ from ‘A+ positive outlook’ and affirmed the Long-Term Issuer Default Rating at ‘A+’.
Fitch Ratings hat das Insurer Financial Strength (IFS)-Rating der SCOR von "A+ mit positivem Ausblick" auf "AA- mit stabilem Ausblick" erhöht und das Long-Term Issuer Default Rating (IDR) von "A+" bestätigt.